NCT00552214

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10,290 (actual)
• Sponsor: Novartis · Industry
• Sex: All
• Age: 17 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to validate the performance characteristics of an assay that tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration submission.

Conditions

• Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Interventions

Type	Name	Description
DEVICE	Blood test	Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens

Timeline

• Start date: 2007-08-08
• Primary completion: 2008-07-01
• Completion: 2008-07-01
• First posted: 2007-11-01
• Last updated: 2021-02-21

Locations

1 site across 1 country: Taiwan